The National Institute of Allergy and Infectious Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order to DXC Technology Company, doing business as DXC, on April 1, 2025. The $10,036.48 contract is for a software license for the DXC Toolbox Pharma Edition, which is used to prepare documents for FDA review processes related to investigational new drugs and drug master files. This contract does not have a set-aside designation, indicating open market competition. DXC Technology Company is the prime contractor, and its parent company, Computer Sciences Corporation (CSC), has provided various IT services and products as a subcontractor on other federal contracts.
Generated 1/3/25, 9:13 AM